AROPAX

This brand name is authorized in Australia, Brazil, New Zealand, South Africa

Active ingredients

The drug AROPAX contains one active pharmaceutical ingredient (API):

1 Paroxetine UNII X2ELS050D8 - PAROXETINE HYDROCHLORIDE

Paroxetine is a potent and selective inhibitor of 5-hydroxytryptamine (5-HT, serotonin) uptake and its antidepressant action and effectiveness in the treatment of OCD, Social Anxiety disorder/Social Phobia, General Anxiety Disorder, Post-Traumatic Stress Disorder and Panic Disorder is thought to be related to its specific inhibition of 5-HT uptake in brain neurones. Read about Paroxetine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AROPAX CR Tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AB05	Paroxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2242B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510600902111311
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6182
Country: ZA	Health Products Regulatory Authority	Identifier(s): A38/1.2/0613, Y/1.2/419